Location History:
- Sapporo, JP (1989 - 2017)
- Hokkaido, JP (2011 - 2019)
Company Filing History:
7 out of 612 
5 out of 416 
4 out of 2,874 
Years Active: 1989-2019
Title: Innovations of Shinichiro Nishimura: Pioneering Antibody Development in Cancer Treatment
Introduction
Shinichiro Nishimura, based in Sapporo, Japan, is a distinguished inventor with a significant contribution to the field of cancer research through his innovative antibody inventions. With a total of 19 patents to his name, Nishimura has been at the forefront of developing methods that enhance cancer diagnosis and treatment.
Latest Patents
Among his notable advancements are two key patents focusing on antibodies: the first patent details an antibody that targets the MUC4 glycopeptide, which is preferentially expressed in cancer cells. This invention also describes a glycopeptide suitable for the production of this antibody, alongside methods for diagnosing, preventing, and treating cancer, particularly malignant tumors.
The second patent pertains to an anti-MUC1 antibody, characterized by its specificity for MUC1, which also shows high levels in cancer cells. This invention provides methods for the antibody’s production and application for cancer diagnosis and treatment, including a pharmacological composition featuring the monoclonal antibody as an active ingredient.
Career Highlights
Nishimura's professional journey includes influential roles at renowned institutions, such as Sumitomo Bakelite Company Limited and Hokkaido University. His work demonstrates a deep commitment to advancing medical science, notably in the development of innovative cancer therapies.
Collaborations
Throughout his career, Nishimura has collaborated with prominent colleagues, including Hiroaki Nakagawa and Hideyuki Shimaoka. These partnerships have enhanced his research efforts and have led to the successful realization of complex antibody innovations.
Conclusion
Shinichiro Nishimura stands out as a key innovator in the field of biotechnology, with his patents reflecting significant contributions to cancer treatment. His ongoing work promises to lead to further advancements in understanding and combating this challenging disease, showcasing the impact of innovative research on health care solutions.